A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
PHASE3CompletedINTERVENTIONAL
Enrollment
349
Participants
Timeline
Start Date
April 30, 1995
Study Completion Date
December 31, 1996
Conditions
DementiaAlzheimer DiseaseDementia, Vascular
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00249145 - A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia | Biotech Hunter | Biotech Hunter